Cerebrolysin is a standardised neuropeptide preparation derived from purified porcine brain protein through controlled enzymatic hydrolysis. The resulting complex contains a defined mixture of low-molecular-weight peptides and free amino acids, with the active peptide fraction accounting for approximately 25% of the total composition. The remaining 75% comprises free amino acids that support the biological activity of the peptide components.
The neuroprotective and neurotrophic effects of Cerebrolysin are attributed to its ability to mimic the actions of endogenous neurotrophic factors. Research indicates it may modulate pathways associated with brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and insulin-like growth factor (IGF-1). Studies have explored its potential role in reducing neuronal apoptosis, attenuating excitotoxicity, and supporting synaptic plasticity.
This 60mg lyophilised preparation is supplied at greater than 98% purity and is intended for in vitro and in vivo preclinical research applications. CAS Number: 12656-61-0. As a complex peptide mixture, a single molecular formula is not applicable. Store at –20°C in a dry environment; reconstituted solutions should be stored at 4°C and used within 14 days.
Molecular Formula
N/A (complex peptide mixture)
Molecular Weight
N/A (low-molecular-weight peptide complex, predominantly <1000 Da)
Purity
>98%
CAS Number
12656-61-0
Form
Lyophilised Powder
Research Applications
Neuroprotection research, Neurotrophic factor modulation, Alzheimer’s disease models, Traumatic brain injury research, Synaptic plasticity studies, Cognitive function research
For research purposes only. Not for human use.
Reviews
There are no reviews yet.